- 26 January 2022
- Journal article
Risk factors for mortality in patients with COVID-19 : the Kuwait experience
- Medical Principles and Practice
Objectives: To describe the baseline characteristics and to evaluate the risk factors for in-hospital mortality in patients admitted to hospitals with coronavirus disease (COVID-19) in Kuwait. Subjects and Methods: This retrospective cohort study analyzed data of patients admitted to two hospitals in Kuwait with COVID-19. The outcome was assessed by using multivariable analysis of factors affecting survival and mortality. Results: In the 962 patients, the case fatality ratio was 9.04%. The mean age of non-survivors was 63.5 ± 14.8 years, and most deaths occurred in males (80.5%). For the whole sample, source of transmission was significantly related to mortality and the median duration of in- hospital stay was 15 (interquartile range: 2–52) days. In patients with high oxygen requirements, the case fatality rate was 96.6%. Multivariable analysis identified age, hypertension, cardiovascular disease, and dyspnoea on presentation as independent risk factors for COVID-19 mortality. Conclusions: The mortality rate was higher in older patients with comorbidities such as hypertension and cardiovascular disease. Early recognition of high-risk patients may help to improve care and reduce mortality.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Al Saleh, M., Alotaibi, N., Schrapp, K., Alsaber, A., Pan, J., Almutairi, F., Abdullah, M., Aboelhassan, W., AlNasrallah, N., Al-Bader, B., Malhas, H., Ramadhan, M., Hamza, M., Abdelnaby, H. & Alroomi, M. 2022, 'Risk factors for mortality in patients with COVID-19 : the Kuwait experience', Medical Principles and Practice. https://doi.org/10.1159/000522166